TRASTUZUMAB-ANNS for Off label use: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 8 adverse event reports in the FDA FAERS database where TRASTUZUMAB-ANNS was used for Off label use.
Most Reported Side Effects for TRASTUZUMAB-ANNS
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Product storage error | 346 | 25.2% | 0 | 0 |
| Circumstance or information capable of leading to medication error | 257 | 18.8% | 0 | 0 |
| Off label use | 104 | 7.6% | 3 | 23 |
| Intercepted product administration error | 89 | 6.5% | 0 | 0 |
| Product dose omission issue | 68 | 5.0% | 0 | 0 |
| Chills | 58 | 4.2% | 0 | 27 |
| Dyspnoea | 52 | 3.8% | 1 | 16 |
| Nausea | 49 | 3.6% | 1 | 10 |
| Diarrhoea | 48 | 3.5% | 2 | 7 |
| Rash | 45 | 3.3% | 0 | 1 |
| Fatigue | 42 | 3.1% | 1 | 3 |
| Intercepted product preparation error | 42 | 3.1% | 0 | 0 |
| Product preparation error | 40 | 2.9% | 0 | 0 |
| Accidental exposure to product | 39 | 2.8% | 0 | 0 |
| Infusion related reaction | 34 | 2.5% | 0 | 2 |
Other Indications for TRASTUZUMAB-ANNS
Product used for unknown indication (871)
Breast cancer (297)
Breast cancer metastatic (36)
Her2 positive breast cancer (34)
Breast cancer female (25)
Her-2 positive breast cancer (10)
Endometrial cancer (9)
Invasive ductal breast carcinoma (8)
Gastric cancer (7)
Oesophageal carcinoma (7)
Other Drugs Used for Off label use
LENALIDOMIDE (5,767)
ECULIZUMAB (3,550)
CERTOLIZUMAB PEGOL (2,256)
ABOBOTULINUMTOXINA (2,170)
LEVETIRACETAM (2,161)
APREMILAST (1,995)
PROPRANOLOL (1,576)
CETIRIZINE (1,416)
HUMAN IMMUNOGLOBULIN G (1,129)
THALIDOMIDE (1,033)